Intelligent Fingerprinting Drug Screening System ISO Recertification

Intelligent Fingerprinting Drug Screening System ISO Recertification.png

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

International certification adds to Quality Management Systems credentials for the medical device industry and supports expansion plans into North America and Asia Pacific regions

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its Intelligent Fingerprinting Drug Screening business has obtained recertification for the latest ISO 13485: 2016 harmonised quality management system standard for the medical device industry. The recertification is effective October 14, 2023, and will be valid for three years.

ISO 13485:2016 is the international standard for medical devices quality management system certification and is a requirement for medical device manufacturers operating across key regions, including the USA, Canada, Europe, Japan, Singapore, Malaysia and Saudi Arabia. Last year the US Food and Drug Administration published a proposed rule to harmonise its medical device quality management system, 21 CFR Part 820, to the ISO 13485 QMS standard.

“Receiving ISO 13485: 2016 certification confirms that our research and development, manufacturing facilities and operations for our drug screening products conform with the highest quality management system requirements for our target markets,” said Harry Simeonidis, President and Chief Executive Officer of Intelligent Bio Solutions. “We are currently focused on driving sales growth for our Intelligent Fingerprinting Drug Screening System across Europe and Australia. In the coming months, we plan to extend our sales efforts into other countries throughout the Asia Pacific region. Given this planned expansion, it is essential we meet the most stringent quality criteria recognised globally.”

The ISO 13485:2016 harmonised standard specifies the requirements for a quality management system where an organisation must demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements. Based on the ISO 9001 process model, ISO 13485 includes particular elements needed for organisations involved in the lifecycle of medical devices. The Intelligent Fingerprinting business has also been recertified for the ISO 9001:2015 quality standard.

The Intelligent Fingerprinting Drug Screening System is designed to detect the presence of specific drugs and/or their metabolites from fingerprint sweat. The system features a small, tamper-evident Drug Screening Cartridge onto which ten fingerprint sweat samples are collected in less than a minute. The tamper-proof Cartridges screen for multiple drug groups simultaneously, including combinations of opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine, in an approach that offers a dignified, non-invasive, and rapid drug screening solution. The application of the technology in maintaining workplace safety has garnered positive feedback from the Company’s growing customer base of over 350 clients worldwide, successfully deterring substance abuse at work and ensuring employee wellbeing and compliance with health and safety policies.

Meet The Author

Intelligent Fingerprinting

Intelligent Fingerprinting

Related Articles

Skilled construction worker

Does workplace drug testing affect staff retention? It can. An intrusive, heavy-handed approach to drug testing at work can quietly push good employees towards the door. People do not forget an experience that felt invasive or accusatory, and for a skilled worker with options, that is one more reason to look elsewhere. This article looks…

Fingerprint drug testing during procurement

Do contracts require a drug and alcohol policy? Increasingly, the answer is yes. For a few sectors it is a legal requirement; for many more it has become a commercial one, written into the pre-qualification questionnaires and supply-chain standards that decide who gets shortlisted. Either way, the direction of travel is the same: a documented…

Fingerprint drug testing cartridge

Is workplace drug testing worth it? A fair question. Most organisations weigh the cost of testing against zero: the price of the kits versus doing nothing at all. Counted that way, testing will always look like an expense to contain. But that sum measures only one side of the ledger. It ignores what a well-run…

Book A Demo

See the difference fingerprint drug testing can make in your workplace. Request a personalised demonstration today.